isoniazida labesfal 300 mg comprimido
labesfal - laboratórios almiro, s.a. - isoniazida - comprimido - 300 mg - isoniazida 310 mg - isoniazid - n/a - duração do tratamento: longa duração
isoniazida labesfal 300 mg comprimido
labesfal - laboratórios almiro, s.a. - isoniazida - comprimido - 300 mg - isoniazida 310 mg - isoniazid - n/a - duração do tratamento: longa duração
isoniazida labesfal 100 mg/ml solução injetável
labesfal - laboratórios almiro, s.a. - isoniazida - solução injetável - 100 mg/ml - isoniazida 100 mg/ml - isoniazid - n/a - duração do tratamento: longa duração
isoniazida labesfal 50 mg comprimido
labesfal - laboratórios almiro, s.a. - isoniazida - comprimido - 50 mg - isoniazida 50 mg - isoniazid - n/a - duração do tratamento: longa duração
isoniazida labesfal 300 mg comprimido
labesfal - laboratórios almiro, s.a. - isoniazida - comprimido - 300 mg - isoniazida 310 mg - isoniazid - n/a - duração do tratamento: longa duração
isoniazida labesfal 50 mg comprimido
labesfal - laboratórios almiro, s.a. - isoniazida - comprimido - 50 mg - isoniazida 50 mg - isoniazid - n/a - duração do tratamento: longa duração
isoniazide apotex 200 mg, tabletten
apotex europe bv archimedesweg 2 2333 cn leiden - isoniazide - tablet - lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel ; siliciumdioxide (e 551), - isoniazid
isoniazid tablet
northwind pharmaceuticals, llc - isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l) - isoniazid 300 mg - isoniazid is recommended for all forms of tuberculos in which organisms are susceptible. however, active tuberculosis must be treated with multiple concomitant antituberculosis medications to prevent the emergence of drug resistance. single-drug treatment of active tuberculos with isoniazid, or any other medication, is inadequate therapy. isoniazid is recommended as preventive therapy for the following groups, regardless of age. (note: the criterion for a positive reaction to a skin test (in millimeters of induration) for each group is given in parenthesis): 1. persons with human immunodeficiency virus (hiv) infection (≥ 5 mm) and persons with risk factors for hiv infection whose hiv infection status is unknown but who are suspected of having hiv infection. preventive therapy may be considered for hiv infected persons who are tuberculin- negative but belong to groups in which the prevalence of tuberculosis infection is high. candidates for preventive therapy who have hiv infection should have a minimum of 12
isoniazid tablet
bryant ranch prepack - isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l) - isoniazid 100 mg - isoniazid tablets are recommended for all forms of tuberculosis in which organisms are susceptible. however, active tuberculosis must be treated with multiple concomitant anti-tuberculosis medications to prevent the emergence of drug resistance. single-drug treatment of active tuberculosis with isoniazid or any other medication, is inadequate therapy. isoniazid tablets are recommended as preventive therapy for the following groups, regardless of age. (note: the criterion for a positive reaction to a skin test (in millimeters of induration) for each group is given in parenthesis): - persons with human immunodeficiency virus (hiv) infection (greater than or equal to 5 mm) and persons with risk factors for hiv infection whose hiv infection status is unknown but who are suspected of having hiv infection. preventive therapy may be considered for hiv infected persons who are tuberculin-negative but belong to groups in which the prevalence of tuberculosis infection is high. candidates for preventive therapy who have
isoniazid tablet
a-s medication solutions - isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l) - isoniazid 300 mg - isoniazid tablets, usp are recommended for all forms of tuberculosis in which organisms are susceptible. however, active tuberculosis must be treated with multiple concomitant anti-tuberculosis medications to prevent the emergence of drug resistance. single-drug treatment of active tuberculosis with isoniazid or any other medication, is inadequate therapy. isoniazid tablets, usp are recommended as preventive therapy for the following groups, regardless of age. (note: the criterion for a positive reaction to a skin test (in millimeters of induration) for each group is given in parenthesis): - persons with human immunodeficiency virus (hiv) infection (greater than or equal to 5 mm) and persons with risk factors for hiv infection whose hiv infection status is unknown but who are suspected of having hiv infection. preventive therapy may be considered for hiv infected persons who are tuberculin-negative but belong to groups in which the prevalence of tuberculosis infection is high. candidates for preventive therap